SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950005-13-000005
Filing Date
2013-02-13
Accepted
2013-02-12 19:53:27
Documents
1
Group Members
ALTA BIOPHARMA MANAGEMENT III, LLCALTA BIOPHARMA PARTNERS III GMBH & CO. BETEILIGUNGS KGALTA BIOPHARMA PARTNERS III, L.P.ALTA EMBARCADERO BIOPHARMA PARTNERS III, LLCEDWARD HURWITZEDWARD PENHOETFARAH CHAMPSI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A e10104_13gathreshold2012.htm SC 13G/A 113957
  Complete submission text file 0000950005-13-000005.txt   115817
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Subject) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81377 | Film No.: 13599176
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 4153624022
ALTA BIOPHARMA PARTNERS III LP (Filed by) CIK: 0001257444 (see all company filings)

IRS No.: 050573803 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A